| [1] |
Shane E, Burr D, Abrahamsen B, et al. Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American society for bone mineral research[J]. J Bone Miner Res, 2014, 29(1): 1-23.
|
| [2] |
Khosla S, Burr D, Cauley J, et al. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American society for bone and mineral research[J]. J Bone Miner Res, 2007, 22(10): 1479-1491.
|
| [3] |
Li Y, Toraldo G, Li A, et al. B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo[J]. Blood, 2007, 109(9) : 3839-3848.
|
| [4] |
Zaiss MM, Axmann R, Zwerina J, et al. Treg cells suppress osteoclast formation: a new link between the immune system and bone[J]. Arthritis and Rheumatism, 2007, 56(12)：4104- 4112.
|
| [5] |
Godwin JW, Pinto AR, Rosenthal NA. Macrophages are required for adult salamander limb regeneration[J]. Proc Natl Acad Sci U S A, 2013, 110 (23) : 9415-9420.
|
| [6] |
Hayday AC. T cells and the lymphoid stress-surveillance response[J]. Immunity, 2009, 31(2): 184-196.
|
| [7] |
Strid J, Roberts SJ , Filler RB, et al. Acute upregulation of an NKG2D ligand promotes rapid reorganization of a local immune compartment with pleiotropic effects on carcinogenesis[J]. Nature Immunology, 2008, 9(2): 146-154.
|
| [8] |
Schmidt-Bleek K, Schell H , Kolar P, er al. Cellular composition of the initial fracture hematoma compared to a muscle hematoma: a study in sheep[J]. J Orthop Res, 2009, 27 (9) : 1147-1151.
|
| [9] |
Lienau J, Schmidt-Bleek K, Peters A, et al. Differential regulation of blood vessel formation between standard and delayed bone healing[J]. J Orthop Res, 2009, 27 (9): 1133-1140.
|
| [10] |
Biswas SK, Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm[J]. Nat Immunol, 2010, 11(10): 889-896.
|
| [11] |
Sica A, Bronte V. Altered macrophage differentiation and immune dysfunction in tumor development[J]. J Clin Invest, 2007, 117(5): 1155-1166.
|
| [12] |
Mantovani A, Sozzani S, Locati M, et al. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes[J]. Trends Immunol, 2002, 23(11): 549-555.
|
| [13] |
Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation[J]. Nat Rev Immunol, 2008, 8(12): 958-969.
|
| [14] |
Vergadi E, Ieronymaki E, Lyroni K, et al. Akt signaling pathway in macrophage activation and M1/M2 polarization[J]. J Immunol, 2017, 198(3): 1006-1014.
|
| [15] |
Irelli A, Sirufo MM, Scipioni T, et al. mTOR Links tumor immunity and bone metabolism: What are the clinical implications？[J]. Int J Mol Sci, 2019, 20(23): 5841.
|
| [16] |
Liu H, Wu X, Gang N, et al. Macrophage functional phenotype can be consecutively and reversibly shifted to adapt to microenvironmental changes[J]. Int J Clin Exp Med, 2015, 8(2): 3044-3053.
|
| [17] |
Wang N, Liang H, Zen K. Molecular mechanisms that influence the macrophage m1-m2 polarization balance[J]. Front Immunol, 2014, 5: 614.
|
| [18] |
Ke X, Chen C, Song Y, et al. Hypoxia modififies the polarization of macrophages and their inflammatory microenvironment, and inhibits malignant behavior in cancer cells[J]. Oncol Lett, 2019, 18(6): 5871-5878.
|
| [19] |
Colegio OR, Chu NQ, Szabo AL, et al. Functional polarization of tumour-associated macrophages by tumour-derived lactic acid[J]. Nature, 2014, 513; 513, 559-563.
|
| [20] |
Ginaldi L, Di Benedetto MC, De Martinis M. Osteoporosis, inflflammation and ageing[J]. Immun Ageing, 2005, 2: 14.
|
| [21] |
Krzyszczyk P, Schloss R, Palmer A, et al. The role of macrophages in acute and chronic wound healing and interventions to promote pro-wound healing phenotypes[J]. Front Physiol, 2018, 9: 419.
|
| [22] |
Wynn TA, Vannella KM. Macrophages in tissue repair, regeneration, and fifibrosis[J]. Immunity, 2016, 44(3): 450-462.
|
| [23] |
Yang DH, Yang MY. The role of macrophage in the pathogenesis of osteoporosis[J]. Int J Mol Sci, 2019, 20(9): 2093.
|
| [24] |
Horwood NJ. Macrophage polarization and bone formation: a review[J]. Clin Rev Allergy Immunol, 2016, 51(1): 79-86.
|
| [25] |
Souza PP, Lerner UH. The role of cytokines in inflflammatory bone loss[J]. Immunol Investig, 2013, 42(7): 555-622.
|
| [26] |
Lind M, Deleuran B, Yssel, H, et al. IL-4 and ZL-13, but not IL-10, are chemotactic factors for human osteoblasts[J]. Cytokine, 1995, 7(1): 78-82.
|
| [27] |
Silfversward CJ, Frost A, Brandstrom H, et al. Interleukin-4 and interleukin-13 potentiate interleukin-1 induced secretion of interleukin-6 in human osteoblast-like cells[J]. J Orthop Res, 2004, 22(5): 1058-1062.
|
| [28] |
Palmqvist P, Lundberg P, Persson E, et al. Inhibition of hormone and cytokine-stimulated osteoclastogenesis and bone resorption by interleukin-4 and interleukin-13 is associated with increased osteoprotegerin and decreased rankl and rank in a stat6-dependent pathway[J]. J Biol Chem, 2006, 281(5): 2414-2429.
|
| [29] |
McGregor NE, Murat M, Elango J, et al. IL-6 exhibits both cis and trans signaling in osteocytes and osteoblasts, but only trans signaling promotes bone formation and osteoclastogenesis[J]. J Biol Chem, 2019, 294(19): 7850-7863.
|
| [30] |
Panagakos FS. Transforming growth factor-alpha stimulates chemotaxis of osteoblasts and osteoblast-like cells in vitro[J]. Biochem Mol Biol Int, 1994, 33(4): 643-650.
|
| [31] |
Sahoo A, Wali S, Nurieva R. T helper 2 and T follicular helper cells: regulation and function of interleukin-4[J]. Cytokine Growth Factor Rev, 2016, 30: 29-37.
|
| [32] |
Rath M, Müller I, Kropf P. Metabolism via arginase or nitric oxide synthase: two competing arginine pathways in macrophages[J]. Front Immunol, 2014, 5: 532.
|
| [33] |
Munder M. Arginase: an emerging key player in the mammalian immune system[J]. Br J Pharmacol, 2009, 158(3): 638-651.
|
| [34] |
Melo-Cardenas J, Bezavada L, Crawford JC, et al. IL-13/IL-4 signaling contributes to fibrotic progression of the myeloproliferative neoplasms[J]. Blood, 2022, 140(26): 2805-2817.
|
| [35] |
Osorio EY, Zhao W, Espitia C, et al. Progressive visceral leishmaniasis is driven by dominant parasite-induced STAT6 activation and STAT6-dependent host arginase 1 expression[J]. PLoS Pathog, 2012, 8(1): e1002417.
|
| [36] |
Muñoz J, Akhavan NS, Mullins AP, et al. Macrophage polarization and osteoporosis: a review[J]. Nutrients, 2020, 12(10): 2999.
|
| [37] |
Liu Q, Liu C, Yang Y, et al. Osteocyte-intrinsic mtorc1 signaling restrains trabecular bone accrual in mice[J]. J Cell Biochem, 2018, 119: 8743-8749.
|
| [38] |
Qu X, Mei J, Yu Z, et al. Lenalidomide regulates osteocytes fate and related osteoclastogenesis via IL-1β/NF-κB/RANKL signaling[J]. Biochem Biophys Res Commun, 2018, 501(2): 547-555.
|
| [39] |
Shukla P, Mansoori MN, Kakaji M, et al. Interleukin 27 (IL-27) alleviates bone loss in estrogen-defificient conditions by induction of early growth response-2 gene[J]. J Biol Chem, 2017, 292(11): 4686-4699.
|
| [40] |
Chhana A, Pool B, Callon KE, et al. Monosodium urate crystals reduce osteocyte viability and indirectly promote a shift in osteocyte function towards a proinflflammatory and proresorptive state[J]. Arthritis Res Ther, 2018, 20(1): 208.
|
| [41] |
Harmer D, Falank C, Reagan MR. Interleukin-6 interweaves the bone marrow microenvironment, bone loss, and multiple myeloma[J]. Front Endocrinol (Lausanne), 2019, 9: 788.
|
| [42] |
Sun W, Meednu N, Rosenberg A, et al. B cells inhibit bone formation in rheumatoid arthritis by suppressing osteoblast difffferentiation[J]. Nat Commun, 2018, 9(1): 5127.
|
| [43] |
Amarasekara DS, Yun H, Kim S, et al. Regulation of osteoclast differentiation by cytokine networks[J]. Immune Netw, 2018, 18(1): e8.
|
| [44] |
Gong L, Zhao Y, Zhang Y, et al. The macrophage polarization regulates msc osteoblast difffferentiation in vitro[J]. Ann Clin Lab Sci, 2016, 46(1): 65-71.
|
| [45] |
Zhang Y, Böse T, Unger RE, et al. Macrophage type modulates osteogenic difffferentiation of adipose tissue MSCs[J]. Cell Tissue Res, 2017, 369(2): 273-286.
|
| [46] |
Arabpour M, Saghazadeh A, Rezaei N. Anti-inflammatory and M2 macrophage polarization-promoting effect of mesenchymal stem cell-derived exosomes[J]．Int Immunopharmacol, 2021, 97: 107823.
|
| [47] |
Moerman EJ, Teng K, Lipschitz DA, et al. Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPAR-γ2 transcription factor and TGF-β/BMP signaling pathways[J]. Aging Cell, 2004, 3(6): 379-389.
|
| [48] |
Li CJ, Cheng P, Liang MK, et al. MicroRNA-188 regulates age-related switch between osteoblast and adipocyte differentiation[J]. J Clin Investig, 2015, 125(4): 1509-1522.
|
| [49] |
Hu L, Yin C, Zhao F, et al. Mesenchymal stem cells: cell fate decision to osteoblast or adipocyte and application in osteoporosis treatment[J]. Int J Mol Sci, 2018, 19(2): 360.
|
| [50] |
Jin H, Yao L, Chen K, et al. Evodiamine inhibits rankl-induced osteoclastogenesis and prevents ovariectomy-induced bone loss in mice[J]. J Cell Mol Med, 2019, 23(1): 522-534.
|
| [51] |
Kim B, Lee KY, Park B. Icariin abrogates osteoclast formation through the regulation of the rankl-mediated TRAF6/NF-κB/ERK signaling pathway in Raw264. 7 cells[J]. Phytomedicine, 2018, 51: 181-190.
|